Wells Fargo & Company Valneva Se Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
A detailed history of Wells Fargo & Company transactions in Valneva Se stock. As of the latest transaction made, Wells Fargo & Company holds 183,110 shares of VALN stock, worth $1.1 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
183,110
Previous 2,520
7166.27%
Holding current value
$1.1 Million
Previous $19,000
6652.63%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding VALN
# of Institutions
13Shares Held
654KCall Options Held
0Put Options Held
0-
General American Investors CO Inc354KShares$2.12 Million0.17% of portfolio
-
Alpha Centric Advisors LLC San Juan, PR88.3KShares$528,6290.51% of portfolio
-
Ironwood Investment Management LLC Boston, MA25KShares$149,8810.1% of portfolio
-
Morgan Stanley New York, NY1.98KShares$11,8540.0% of portfolio
-
Ridgewood Investments LLC550Shares$3,2940.0% of portfolio
About Valneva SE
- Ticker VALN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,103,504
- Market Cap $414M
- Description
- Valneva SE, a specialty vaccine company, focuses on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. Its commercial vaccines for travelers include IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; ...